Anand Kumar, MD
Pharmacology and Therapeutics, Max Rady College of Medicine
Dr. Anand Kumar is on a mission to uncover the secrets of septic shock and unlock new ways to save lives. He's a leading expert in the field, using cutting-edge techniques in in-vitro and animal models to study the complex mechanisms of human pathophysiology and infections. With a particular focus on the ICU management of pandemics like COVID-19, Dr. Kumar is working to understand the underlying causes of septic shock and develop new treatments to improve outcomes for patients.
As the head of the Cooperative Antimicrobial Therapy of Septic Shock Research Group, and a member of the CHIRON Research Group, Dr. Kumar is leading a team of researchers in the fight against septic shock. They're using a small animal model of septic shock and a clinical septic shock database with over 9000 patients, which is the largest and most complete in existence to study the disease from every angle.
Dr. Kumar's research has already made major breakthroughs in understanding how to optimize antimicrobial therapy in critical illness and how to improve outcomes for patients suffering from septic shock. His seminal paper on the topic has been cited over 5000 times and is recognized as one of the top 10 most highly cited papers in the field of sepsis and antibiotic research.
Inflammatory myocardial dysfunction
ICU management of pandemic infections
Optimizing antimicrobial therapy in critical illness
Head, Cooperative Antimicrobial Therapy of Septic Shock Research Group
Member, CHIRON Research Group
- Antimicrobial therapy
- Circulatory shock
- Clinical epidemiology
- H1N1 influenza
- ICU management
- Inflammatory myocardial dysfunction
- Molecular biology
- Septic shock
Dr. Anand Kumar is a renowned expert in the field of critical care medicine and infectious diseases. He currently holds the position of professor in the Max Rady College of Medicine, with cross-appointments in the departments of Medical Microbiology and Pharmacology and Therapeutics. He is also an attending physician at the Health Sciences Centre and St-Boniface Hospital.
Dr. Kumar completed his residency in internal medicine at the Toronto Hospital—University of Toronto and subsequently completed fellowships in critical care medicine and cardiovascular research.
Dr. Kumar is trained in internal medicine, critical care medicine and infectious diseases with translational research interests in sepsis/septic shock, life-threatening infections and severe epidemic/pandemic infections. He has published over 450 original research manuscripts, reviews/chapters and abstracts
Fellowship in Infectious Diseases, University of Wisconsin, Madison (1996)
Research Fellowship in Cardiovascular function in sepsis (1994)
Fellowship in Critical Care Medicine, Rush University (1991)
Fellowship in Critical Care Medicine, University of Manitoba (1990)
Residency in Internal Medicine, The Toronto Hospital (1989)
Doctor of Medicine, University of Toronto (1986)
Young Investigator Educational Scholarship Award, Society of Critical Care Medicine (1993)
DuPont Pharmaceuticals/ACCP Young Investigator Award, American College of Chest Physicians (1993)
DuPont Pharmaceuticals/ACCP Critical Care Research Award Finalist, American College of Chest Physicians (1993)
Cecile Lehman Mayer Award Finalist, American College of Chest Physicians (1993)
Internal Medicine Specialty Award, Society of Critical Care Medicine (1994)
Canadian Critical Care Society Arrow Young Investigator Award (1994)
In-Training Young Investigator Award, Society of Critical Care Medicine (1995)
Young Investigator Award, Society of Critical Care Medicine (1998)
Best Abstract, 2nd place, Toronto Critical Care Medicine Symposium, as senior author (1st author John Ronald) (2004)
Soffer Award for best abstract nominee, ACCP Annual Symposium, as senior author (1st author Sat Sharma) (2004)
Internal Medicine Award, Society of Critical Care Medicine (2005)